Create an account to receive alerts on new research
SaveShareAsk AI
Sertraline

Sertraline Side Effects & Health Impacts

Nutrient depletion caused by Sertraline can lead to a range of health impacts. This medication is commonly used for Depression.

Side Effects

Some common side effects of the antidepressant drug sertraline include:

1. Nausea or vomiting
2. Diarrhea
3. Dizziness or lightheadedness
4. Drowsiness or fatigue
5. Insomnia or trouble sleeping
6. Headache
7. Dry mouth
8. Loss of appetite
9. Weight changes
10. Sexual side effects, such as decreased libido or difficulty achieving orgasm

More serious side effects that may require immediate medical attention include:

1. Suicidal thoughts or behaviors
2. Severe allergic reactions, such as rash, hives, swelling, or difficulty breathing
3. Seizures
4. Manic episodes or signs of bipolar disorder
5. Changes in heart rate or blood pressure
6. Serotonin syndrome, a potentially life-threatening condition characterized by high levels of serotonin in the body, which can cause symptoms such as agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, and diarrhea.

It is important to discuss any side effects you experience with your healthcare provider, as they may be able to adjust your dosage or switch you to a different medication. Do not stop taking sertraline without consulting your healthcare provider, as this can lead to withdrawal symptoms.

Health Impacts

Sertraline may deplete important nutrients your body relies on every day. These changes often occur gradually as medications affect nutrient absorption, metabolism, or utilization. Over time, low nutrient levels can contribute to fatigue, neurological symptoms, metabolic issues, and reduced resilience. Addressing these depletions can help support long-term health while continuing necessary treatment.

High Homocysteine & Vascular Risk

Folate depletion impairs one-carbon metabolism, leading to elevated homocysteine, endothelial dysfunction and potential promotion of atherothrombotic events.

Meta-analyses of randomized trials show that folic acid supplementation lowers homocysteine and modestly reduces stroke and overall cardiovascular disease risk in some populations, especially where baseline folate status is low, highlighting the adverse vascular profile of folate deficiency.

Li Y et al. Folic acid supplementation and the risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2016;5(8):e003768.; Wang Y et al. The effect of folic acid in patients with cardiovascular disease: a meta-analysis. Medicine (Baltimore). 2019;98(38):e17106.; Miller ER et al. Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease. Am J Cardiol. 2010;106(4):517-527.

Read more about High Homocysteine & Vascular Risk

Reduced Insulin Sensitivity

Chromium is a cofactor for insulin signaling complexes; inadequate chromium status has been associated in some studies with impaired glucose tolerance and worsened glycemic control, though human data are mixed.

A systematic review and meta-analysis of chromium supplementation in type 2 diabetes suggests small improvements in fasting glucose and HbA1c in some trials, but high-quality randomized studies in prediabetes found no clear benefit, indicating that the clinical impact of chromium depletion remains uncertain.

Asbaghi O et al. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2020;161:105098.; Ali A et al. Chromium effects on glucose tolerance and insulin sensitivity in persons at risk for diabetes. Diabetes Care. 2011;34(4):712-714.; Talab AT et al. Effects of chromium picolinate supplementation on glycemic status and lipid profile in type 2 diabetes. Clin Nutr Res. 2020;9(2):97-105.

Read more about Reduced Insulin Sensitivity

Unfavorable Metabolic Profile

Low chromium status has been linked observationally to dyslipidemia and features of metabolic syndrome, although causality and clinical significance remain debated.

Narrative reviews highlight associations between low chromium and metabolic derangements, yet interventional trials show heterogeneous results, suggesting that any effect of depletion is modest and context-dependent.

Anderson RA. Chromium and insulin resistance. Nutr Res Rev. 2000;13(2):267-286.; Asbaghi O et al. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes. Pharmacol Res. 2020;161:105098.

Read more about Unfavorable Metabolic Profile
Next Steps
Save this report and share it with your healthcare provider or a family member
Ask our expert AI assistant additional questions related to Sertraline.